Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma

Published:2021-08-27 Issue:1 Volume:33 Page:e818-e821
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Hashimoto Mamoru,Nakayama Takahito,Fujimoto Saizo,Inoguchi Shunsuke,Nishimoto Mitsuhisa,Kikuchi Takashi,Adomi Shogo,Banno Eri,De Velasco Marco A.,Saito Yoshitaka,Shimizu Nobutaka,Mori Yasunori,Minami Takafumi,Fujita Kazutoshi,Nozawa Masahiro,Nose Kazuhiro,Yoshimura Kazuhiro,Uemura Hirotsugu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference31 articles.

1. Role of cytokine therapy for renal cell carcinoma in the era of targeted agents.;Koneru;Curr Oncol,2009

2. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.;Motzer;J Clin Oncol,2009

3. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.;Sternberg;j Clin Oncol,2010

4. NCCN guidelines insights: kidney cancer, version 1.2021.;Motzer;J Natl Compr Canc Netw,2020

5. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.;Powles;Lancet Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gradual and Remarkable Tumor Shrinkage Following Seven-Fraction Stereotactic Radiosurgery Alone With a Marginal Dose of 48.3 Gy for Large Lobar Possibly Intra-sulcal Brain Metastasis From Renal Cell Carcinoma;Cureus;2023-03-19

2. Antineoplastics;Reactions Weekly;2022-04